A hybrid geometric phase II/III clinical trial design based on treatment failure time and toxicity

DOI10.1016/j.jspi.2011.10.016zbMath1232.62154WikidataQ40109131 ScholiaQ40109131MaRDI QIDQ665054

Peter F. Thall, Hoang Q. Nguyen, Johannes E. Wolff, Xue-Mei Wang

Publication date: 5 March 2012

Published in: Journal of Statistical Planning and Inference (Search for Journal in Brave)

Full work available at URL: http://europepmc.org/articles/pmc3249838

zbMATH Keywords

Bayesian design; treatment selection

Mathematics Subject Classification ID

62P10: Applications of statistics to biology and medical sciences; meta analysis

62F15: Bayesian inference

92C50: Medical applications (general)